These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
53 related articles for article (PubMed ID: 9586069)
21. Techniques to analyze the HIV-1 Tat and TAR RNA-dependent recruitment and activation of the cyclin T1: CDK9 (P-TEFb) transcription elongation factor. Gomes N; Garber ME; Jones KA Methods Enzymol; 2003; 371():324-36. PubMed ID: 14712711 [No Abstract] [Full Text] [Related]
22. Influence of generation 2-5 of PAMAM dendrimer on the inhibition of Tat peptide/ TAR RNA binding in HIV-1 transcription. Wang W; Guo Z; Chen Y; Liu T; Jiang L Chem Biol Drug Des; 2006 Dec; 68(6):314-8. PubMed ID: 17177893 [TBL] [Abstract][Full Text] [Related]
23. In vitro selection of aptamers from RNA libraries. Kenan DJ; Keene JD Methods Mol Biol; 1999; 118():217-31. PubMed ID: 10549525 [No Abstract] [Full Text] [Related]
24. Aptamers targeted to an RNA hairpin show improved specificity compared to that of complementary oligonucleotides. Darfeuille F; Reigadas S; Hansen JB; Orum H; Di Primo C; Toulmé JJ Biochemistry; 2006 Oct; 45(39):12076-82. PubMed ID: 17002307 [TBL] [Abstract][Full Text] [Related]
25. The TAR hairpin of human immunodeficiency virus type 1 can be deleted when not required for Tat-mediated activation of transcription. Das AT; Harwig A; Vrolijk MM; Berkhout B J Virol; 2007 Jul; 81(14):7742-8. PubMed ID: 17494072 [TBL] [Abstract][Full Text] [Related]
26. Structural effect of complete [Rp]-phosphorothioate and phosphorodithioate substitutions in the DNA strand of a model antisense inhibitor-target RNA complex. Furrer P; Billeci TM; Donati A; Kojima C; Karwowski B; Sierzchala A; Stec W; James TL J Mol Biol; 1999 Jan; 285(4):1609-22. PubMed ID: 9917400 [TBL] [Abstract][Full Text] [Related]
27. In vitro selection of aptamers that act with Zn2+. Kawakami J; Imanaka H; Yokota Y; Sugimoto N J Inorg Biochem; 2000 Nov; 82(1-4):197-206. PubMed ID: 11132628 [TBL] [Abstract][Full Text] [Related]
28. In vitro transport and delivery of antisense oligonucleotides. Hughes J; Astriab A; Yoo H; Alahari S; Liang E; Sergueev D; Shaw BR; Juliano RL Methods Enzymol; 2000; 313():342-58. PubMed ID: 10595365 [TBL] [Abstract][Full Text] [Related]
29. DNA and RNA sequencing utilizing phosphorothioate chemistry. Gish G; Eckstein F Nucleic Acids Symp Ser; 1987; (18):253-6. PubMed ID: 2447567 [TBL] [Abstract][Full Text] [Related]
30. Chiral and steric effects in the efficient binding of alpha-anomeric deoxyoligonucleoside N-alkylphosphoramidates to ssDNA and RNA. Laurent A; Naval M; Debart F; Vasseur JJ; Rayner B Nucleic Acids Res; 1999 Nov; 27(21):4151-9. PubMed ID: 10518605 [TBL] [Abstract][Full Text] [Related]
31. In vitro selection of phosphorothiolated aptamers. Jhaveri S; Olwin B; Ellington AD Bioorg Med Chem Lett; 1998 Sep; 8(17):2285-90. PubMed ID: 9873529 [TBL] [Abstract][Full Text] [Related]
32. Extending the chemistry that supports genetic information transfer in vivo: phosphorothioate DNA, phosphorothioate RNA, 2'-O-methyl RNA, and methylphosphonate DNA. Thaler DS; Liu S; Tombline G Proc Natl Acad Sci U S A; 1996 Feb; 93(3):1352-6. PubMed ID: 8577768 [TBL] [Abstract][Full Text] [Related]
33. Synthesis and anti-HIV activity of oligoribonucleotides and their phosphorothioate analogs. Agrawal S; Tang JY; Sun D; Sarin PS; Zamecnik PC Ann N Y Acad Sci; 1992 Oct; 660():2-10. PubMed ID: 1340121 [No Abstract] [Full Text] [Related]
34. In vitro selection of RNA aptamers. Marshall KA; Ellington AD Methods Enzymol; 2000; 318():193-214. PubMed ID: 10889989 [No Abstract] [Full Text] [Related]
35. Evolution of a phosphorothioate RNA library during in vitro selection. Kawakami J; Sugimoto N Nucleic Acids Symp Ser; 1997; (37):201-2. PubMed ID: 9586069 [TBL] [Abstract][Full Text] [Related]
36. LNA derivatives of a kissing aptamer targeted to the trans-activating responsive RNA element of HIV-1. Lebars I; Richard T; Di Primo C; Toulmé JJ Blood Cells Mol Dis; 2007; 38(3):204-9. PubMed ID: 17300966 [TBL] [Abstract][Full Text] [Related]
37. Regulating eukaryotic gene expression with aptamers. Toulmé JJ; Di Primo C; Boucard D FEBS Lett; 2004 Jun; 567(1):55-62. PubMed ID: 15165893 [TBL] [Abstract][Full Text] [Related]
38. The synthesis of alternating alpha,beta-oligodeoxyribonucleotides with alternating (3'-->3')- and (5'-->5')-internucleotic linkages as potential therapeutic agents. Koga M; Geyer SJ; Regan JB; Beaucage SL Nucleic Acids Symp Ser; 1993; (29):3-4. PubMed ID: 8247779 [TBL] [Abstract][Full Text] [Related]
39. Mirror-design of L-oligonucleotide ligands binding to L-arginine. Nolte A; Klussmann S; Bald R; Erdmann VA; Fürste JP Nat Biotechnol; 1996 Sep; 14(9):1116-9. PubMed ID: 9631062 [TBL] [Abstract][Full Text] [Related]
40. Biochemical and functional interactions between HIV-1 Tat protein and TAR RNA. Rana TM; Jeang KT Arch Biochem Biophys; 1999 May; 365(2):175-85. PubMed ID: 10328810 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]